Superior response and survival of intensive chemotherapy over venetoclax plus azacitidine in newly diagnosed KIT-mutated acute myeloid leukemia
Abstract Although KIT mutations hold significant prognostic value in acute myeloid leukemia (AML), their impact on selecting first-line treatment remains unclear. This retrospective study of 222 newly diagnosed AML patients therefore compared the efficacy of venetoclax plus azacitidine (VA) versus i...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer
2026-02-01
|
| Serier: | Annals of Hematology |
| Fag: | |
| Online adgang: | https://doi.org/10.1007/s00277-026-06841-4 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
